We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$372M
AUM Growth
+$10.5M
Cap. Flow
+$3.66M
Cap. Flow %
0.99%
Top 10 Hldgs %
17.28%
Holding
264
New
49
Increased
26
Reduced
48
Closed
45

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$3.95M
2
GNRC icon
Generac Holdings
GNRC
+$3.69M
3
XYL icon
Xylem
XYL
+$3.63M
4
CHRW icon
C.H. Robinson
CHRW
+$3.57M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$3.51M

Top Sells

Rank Stock Value
1
IPXL
Impax Laboratories, Inc.
IPXL
+$3.89M
2
PPC icon
Pilgrim's Pride
PPC
+$3.75M
3
CL icon
Colgate-Palmolive
CL
+$3.58M
4
WNC icon
Wabash National
WNC
+$3.19M
5
USNA icon
Usana Health Sciences
USNA
+$3.01M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 16.03%
3 Consumer Discretionary 15.97%
4 Materials 12.67%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNFI icon
76
United Natural Foods
UNFI
$3.08B
$2.13M 0.57%
50,000
– –
DLTR icon
77
Dollar Tree
DLTR
$24.4B
$2.13M 0.57%
25,000
-10,000
-29% -$922K
MRK icon
78
Merck
MRK
$322B
$2.12M 0.57%
+36,680
New +$2.07M
BKU icon
79
Bankunited
BKU
$3.37B
$2.1M 0.57%
51,500
+50,000
+3,333% +$2.07M
RH icon
80
RH
RH
$3.13B
$2.1M 0.56%
15,000
-15,000
-50% -$1.63M
KBH icon
81
KB Home
KBH
$3.37B
$2.09M 0.56%
76,700
-1,800
-2% -$48.4K
AU icon
82
AngloGold Ashanti
AU
$40.1B
$2.05M 0.55%
250,000
+75,000
+43% +$656K
CDW icon
83
CDW
CDW
$18.9B
$2.02M 0.54%
25,000
– –
CZZ
84
DELISTED
Cosan Limited
CZZ
$1.98M 0.53%
+260,000
New +$2.44M
NEO icon
85
NeoGenomics
NEO
$1.96B
$1.97M 0.53%
+150,000
New +$1.65M
CORT icon
86
Corcept Therapeutics
CORT
$12.4B
$1.97M 0.53%
+125,000
New +$2.17M
FN icon
87
Fabrinet
FN
$15.6B
$1.92M 0.52%
+52,000
New +$1.78M
SEM
88
DELISTED
Select Medical
SEM
$1.92M 0.52%
195,808
– –
KNX icon
89
Knight Transportation
KNX
$11.3B
$1.91M 0.51%
50,000
-2,160
-4% -$88.9K
LULU icon
90
lululemon athletica
LULU
$13.5B
$1.87M 0.5%
15,000
-20,000
-57% -$2.13M
CNC icon
91
Centene
CNC
$30.7B
$1.85M 0.5%
30,000
-40,000
-57% -$2.31M
AKAM icon
92
Akamai
AKAM
$16.7B
$1.83M 0.49%
+25,000
New +$1.88M
CERN
93
DELISTED
Cerner Corp
CERN
$1.79M 0.48%
30,000
-30,000
-50% -$1.78M
EHC icon
94
Encompass Health
EHC
$11B
$1.79M 0.48%
33,185
-31,425
-49% -$1.57M
MPC icon
95
Marathon Petroleum
MPC
$92.4B
$1.75M 0.47%
+25,000
New +$1.91M
BG icon
96
Bunge Global
BG
$20.4B
$1.74M 0.47%
25,000
– –
UI icon
97
Ubiquiti
UI
$33.7B
$1.69M 0.46%
20,000
-10,000
-33% -$784K
PTCT icon
98
PTC Therapeutics
PTCT
$5.68B
$1.69M 0.45%
+50,000
New +$1.56M
WPM icon
99
Wheaton Precious Metals
WPM
$49.5B
$1.65M 0.45%
75,000
+70,000
+1,400% +$1.51M
HBI
100
DELISTED
Hanesbrands
HBI
$1.65M 0.44%
75,000
-25,000
-25% -$472K
2 3
4
5 6

Similar funds

CPIM
Coalescence Partners Investment Management New York $463M AUM 8.27% 1-Year Est. Return
SHWM
Smith & Howard Wealth Management Atlanta, Georgia $462M AUM 12.39% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $463M AUM
NG
NatWest Group Edinburgh, Scotland, United Kingdom $462M AUM 47.31% 1-Year Est. Return
PC
ParaFi Capital New York $462M AUM 12.81% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Hussman Strategic Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Hussman Strategic Advisors held 264 positions worth $372M, up 2.9% from $361M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hussman Strategic Advisors's Q2 2018 filing shows 49 new, 26 increased, 48 reduced and 45 closed positions. Its largest new stake was Fastenal: 304,800 shares worth $3.67M. The largest sale was Impax Laboratories, Inc., an estimated $3.89M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Hussman Strategic Advisors's largest Q2 2018 buy was Fastenal: 304,800 shares worth $3.67M.
  • Hussman Strategic Advisors added most to C.H. Robinson in Q2 2018, an estimated $3.57M increase.
  • Hussman Strategic Advisors's biggest Q2 2018 reduction was Varian Medical Systems, Inc., cutting an estimated $2.99M.
  • Hussman Strategic Advisors fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $3.89M.
  • Hussman Strategic Advisors's ten largest holdings make up 17% of its $372M portfolio in Q2 2018.
  • Hussman Strategic Advisors opened 49 new positions and closed 45 in Q2 2018.
  • Hussman Strategic Advisors's portfolio value rose 2.9% quarter-over-quarter to $372M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2018, filed 31 Jul 2018.